9/8/201519/8/20151 8-Sep-15 1 CONFLICT OF INTEREST CONFLICT OF INTEREST Proposed Code Of Conduct for IAP CoI Advisors, Office Bearers & Members Prof. A.

Slides:



Advertisements
Similar presentations
4 th Meeting of the EC International Dialogue on Bioethics Copenhagen, June 19 th, 2012 Large research and medical databases in clinical and research multi-centred.
Advertisements

1 WHO Conflicts of Interest Policy for WHO Experts.
Managing Conflicts of Interest
Guidelines for Non-FTE (Trainees) for NIH-Related Activities, Outside Activities and Awards Issued April 24, 2009 Revised May 22, 2009.
Continuing Professional Development Conflict of Interest This presentation has been developed by the COI Working Group to assist in the implementation.
By Laws and Policy Events Requirements Section 5: Contracts with Third Party Providers 1.Contracts shall ensure: protection of data; financial transparency.
Conflict of Interest (COI) Objectives: Provide an overview of financial conflict of interest (FCOI) related to research activities at Gillette Describe.
1 UMass Dartmouth Conflicts of Interest Policies UMass Dartmouth Liz Rodriguez February 17, 2011.
POSTGRADUATE SEMINAR GUIDELINES
Managing Conflicts of Interest © ACCME.
Conflict of Interest: Dartmouth College. Why do we care about it ? Conflict of Interest in Research : Unbiased research: design, conduct, reporting Maintain.
Conflict of Interest.
Professional Behaviour
Conservation District Supervisor Accreditation Module 2: District Clerk: Roles & Responsibilities.
CPME Comité Permanent des Médecins Européens Standing Committee of European Doctors Doctors and industry - European perspective International.
An Overview of the Student Loan Practices Code of Conduct Richard W. Buck Associate General Counsel University of North Florida Office of the General Counsel.
Conflicts of Interest in Research: Policies and Regulations Marie Barron, M.A., COI Program Specialist Rick Lyons, M.D., Ph.D., COI Committee C Chair.
GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.
1 Arja Kuula, Development Manager, Finnish Social Science Data Archive, University of Tampere Ethics Review in Finland IASSIST conference 2010 Cornell.
Conflict of Interest Faculty & Staff of Instruction or Research Human Resources 2011.
PMA CME CODE Article VII, Section 3 of the PMA By-Laws PMA CME CODE.
Promoting Objectivity in Research by Managing, Reducing, or Eliminating Conflicts of Interest UT HOP UT HOP The University of Texas at Austin.
COI Management Planning A guide and tutorial to assist with the development and drafting of a Conflict of Interest Management Plan.
Institute of Actuaries of India
Fundamentals of Trusteeship. Welcome Michael Mizzoni Deputy General Counsel Department and Board of Higher Education.
Conflict of Interest Michelle Stickler, DEd Office for Research Protections
Voluntary Codes MassMEDIC Meeting Are You Ready to Comply with Massachusetts’ New Pharmaceutical and Medical Device Code of Conduct Law? Linda D. Bentley,
New Staff Orientation: Industry Relations Emory School of Medicine Zainab R. Wurie, JD July 15, 2014.
San Antonio – 2001 Chapter Chairs Workshop Funding Chapter Programs.
PRINCIPALS' MEETING JULY 25, 2013 Krishna University, Machilipatnam V. VENKAIAH VICE-CHANCELLOR.
Engineering Ethics.
CONFLICTS OF INTEREST PRESENTED BY THE UMMC OFFICE OF INTEGRITY AND COMPLIANCE.
Research Conflicts of Interest: Identifying and Minimizing COI from the Perspective of Faculty July 30, 2009 PonJola Coney, MD Senior Associate Dean for.
Continuing Professional Development (CPD)
+ Conflict of Interest in Physician-Industry Relationships.
Dr. Arun Gupta Convener Alliance Against Conflict of Interest (AACI) Conflict of Interest-the Hidden Face of Corruption.
Program Co-Development in CME: Where have we been? Where are we going? Workshop Facilitators: Dr. Craig Campbell Dr. Jamie Meuser September 21,
University of Pittsburgh Presentation to Schools of Pharmacy and Nursing: Consulting Requirements within the Industry Relationship Policy Presented by.
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
CODE OF ETHICAL CONDUCT FOR MEMBERS OF PARLIAMENT.
1 Department Chairs’ Forum October 23, 2003 APM-020 and APM-025 Richard A. Luben.
Acknowledgements and Conflicts of interest Dr Gurpreet Kaur Associate Professor Dept of Pharmacology Government Medical College Amritsar.
Retha Britz Copyright 2013 All rights reserved for this presentation 1 Other important considerations for RECs Retha Britz.
Ps The behavior analyst maintains the high standards of professional behavior of the professional organization This means that when you are working,
New Federal Policy on Financial Conflicts of Interest Matt Richter, MA, JD anticipated 2012 COI Program Specialist Office of Research Policy
Partners Conflict of Interest Policy and Reporting October 11, 2012.
Copyright © Harvard Medical School. All Rights Reserved. Outside Activity Report: What Do I Need to Report?
Education & Programs Committees Workshop Kenneth R. Gehringer, AIA, CSI, CCCA NER Education Committee Chair.
Transparency of payments to healthcare professionals: ABPI plans for a central platform for individual disclosures 2016 June 2014.
Americans with Disabilities Act (ADA) 1990 What Teachers Should know about Title II – Public Educational Institutions. Presented by Janie Beverley.
1 The Nature of Ethics Ethics is generally concerned with rules or guidelines for morals and/or socially approved conduct Ethical standards generally apply.
From Jan 1, no freebies for docs from pharma firms.
Ethical Considerations Dr. Richard Adanu Editor-in-Chief International Journal of Gynecology and Obstetrics (IJGO)
To Disclose or Not to Disclose That is The Question
The IVD Australia Code of Conduct Edition 2.1
Disclosure UK Talking about Transparency.
IRB Open House Conflicts of Interest and Financial Conflicts of Interest in Research May 19, 2017 Office of Policy Coordination, Division of Outside.
“Conflicts of Interest”
Disclosure UK Talking about Transparency.
2018 Canadian Transplant Summit - DISCLOSURE FORM
University of Pittsburgh
Speaker Disclosure slides for presentations
The Japan Diabetes Society
AGREEMENT FOR TRANSPARENCY The Case of Mexico
Industry Induction Course
Use the following slide to disclose any conflicts of interest
We have no conflict of interests related to
COI Disclosure Japan Diabetes Society
The Japan Diabetes Society
Financial Disclosure Financial Interest / Affiliation
Presentation transcript:

9/8/201519/8/ Sep-15 1 CONFLICT OF INTEREST CONFLICT OF INTEREST Proposed Code Of Conduct for IAP CoI Advisors, Office Bearers & Members Prof. A. PARTHASARATHY Distinguished Professor of Pediatrics, The Tamil Nadu Dr. MGR Medical University, Chennai Former Senior Clinical Professor of Pediatrics, Madras Medical College & Deputy Superintendent, Institute of Child Health And Hospital for Children, Chennai National President (1997), Indian Academy of Pediatrics, Regional Advisor (1997–1999) Association of Pediatric Societies of South East Asia Region, Editor-in-chief, IAP Text Book of Pediatrics since 1997 Associate Editor, Color Atlas of Tropical Pediatrics, AAP publication (2009) Advisor, IAP Committee on Immunization, ( ) Mobile:

9/8/20152 Situational Analysis - 1 Organizing committees of National, Zonal, State, District level IAP Conferences accept huge donations from Vaccine manufacturers and other Pharma companies. Sponsored Sessions on the topic of Interest by the Sponsors are allotted special slots of their choice including prime -time slots. Speakers are selected by the Sponsors from their own faculty archive their travel & accommodation are taken care of by the sponsors.

9/8/20153 Situational Analysis - 2 Some Vaccine Manufacturers even pay a 'Lecture Fee' to the selected speaker in the form of cash payment attracting wide criticism from members at large.. Some Speakers even use the Company slides on particular Vaccine and present the same in State/District level Conferences Some openly declare that they have received hospitality and remuneration from the sponsor; Majority do not declare. A felt need for developing 'A Code Of Conduct' suggested in many IAP Forums including during CoI meetings.

9/8/20154 'THE MCI GUIDELINES’ The Faculty Member/Chair -Person can take sponsorship of air Travel, accommodation and local hospitality from their Sponsors for self and Not for their family members. He/She will not receive any remuneration directly or indirectly from Sponsors and also any hidden gift in cash/kind. The sponsorship is meant only for the Conference/CME event and not for any sight seeing trip etc. An agreement / declaration,if, needed can be obtained from the Speaker by the Sponsor and the MCI to be notified of such sponsorship from time to time. A Memento within the specified amount can be handed over to the speaker by the Organizers An Ordinary delegate who is not a Faculty should NOT take any sponsorship for himself and Family for Air Travel/Local accommodation etc.

9/8/20155 Proposed Code of conduct for IAP COI members, office-bearers & advisors - 1 a) Cash or monetary grants: A member/ office-bearer/advisor shall not receive any cash or monetary grants from any vaccine manufacturer for individual purpose in individual capacity under any pretext. b) Travel facilities: A member/ office-bearer/advisor shall not accept any travel facility inside the country or outside, including rail, air, ship, cruise tickets, paid vacations etc. from any vaccine manufacturer for self and family members for vacation or for attending conferences, seminars, workshops, CME programme etc as a faculty or delegate. c) Hospitality: A member/ office-bearer/advisor shall not accept individually any hospitality like hotel accommodation for self and family members from vaccine manufacturers under any pretext.

9/8/20156 Proposed Code of conduct for IAP COI members, office-bearers & advisors - 2 d) Vaccine trials and other research projects: A member/ office-bearer/advisor may participate in; work in research projects funded by vaccine manufacturers. However, they are obliged to know that the fulfillment of the following items (i) to (v) will be an imperative for undertaking any research assignment / project funded by industry – for being proper and ethical. Thus, in accepting such a position a member/ office-bearer/advisor shall:- (i) Ensure that the particular research proposal(s) has the due permission from the competent concerned authorities. (ii) Ensure that such a research project(s) has the clearance of national / state/institutional ethics committees / bodies. (iii) Ensure that it fulfils all the legal requirements prescribed for medical research. (iv) Ensure that the source and amount of funding is publicly disclosed at the beginning itself. (v) Ensure that while accepting such an assignment a member shall have the freedom to publish the results of the research in the greater interest of the society by inserting such a clause in the MoU or any other document agreement for any such assignment.

9/8/20157 Proposed Code of conduct for IAP COI members, office-bearers & advisors - 3 f) Maintaining Professional Autonomy while delivering any scientific talk/lecture/presentation: A member/ office-bearer/advisor are expected to use his/her own slides/teaching material while delivering any talk/presentation in any CME/conference/update on any vaccine. A member/ office-bearer/advisor shall always ensure that there shall never be any compromise either with his / her own professional autonomy and / or with the autonomy and freedom of the committee. g) Affiliation as an advisory board member: A member/ office-bearer/advisor may work for any vaccine manufacturer in advisory capacities, as consultants, as researchers, or in any other professional capacity. In doing so, a member/ office-bearer/advisor shall always: (i) Ensure that his professional integrity and freedom are maintained. (ii) Ensure that such affiliations are within the law. (ii) Ensure that such affiliations / employments are fully transparent and disclosed.

9/8/20158 Proposed Code of conduct for IAP COI members, office-bearers & advisors - 4 h) Endorsement of any vaccine brand: A member/ office-bearer/advisor shall not endorse any vaccine brand (of vaccine manufacturer) publically. Any study conducted on the efficacy or otherwise of such products shall be presented to and / or through appropriate scientific bodies or published in appropriate scientific journals in a proper way. However, a member/ office-bearer/advisor can accept the hospitality/travel grants (but no cash honoraria) from the organizing local IAP branch/other professional associations for delivering lectures/ppts in a meet/CME/symposium/conference or participating in discussion as a faculty member. i) Declaration for CoI meetings: All experts invited to a meeting to develop guidelines or recommendations, as well as assessments of any kind of product, or methodology which would in any way be of relevance to a present or future commercial activity or interests, should complete the Declaration.

9/8/20159 Proposed Code of conduct for IAP COI members, office-bearers & advisors - 5 Declaration : I, ____________________________________________________ hereby (print or type first name, middle initial, last name) declare that I have read all the above terms and conditions associated with working with the committee. I will abide by all the above terms while discharging the duty of a member/office-bearer/advisor of the committee till my appointment lasts. In case of any conflict of interest, I will not only declare it to the committee, but will also resolve it before undertaking any such duty that may involve such issues. ______________________________ (Signature) (Date ) _______________________________ (Name ) (Institution)